MCTA
·NASDAQ
--
--(--)
--
--(--)
MCTA fundamentals
During H1 2026, (MCTA) reported revenue of 2.16M, a YoY change of -26.99%. Net income was -72.98K, a YoY change of -115.57%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
FY,2023 | H1,2024 | FY,2024 | H1,2025 | FY,2025 | H1,2026 | TTM |
|---|
Start Date | Apr 1, 2022 | Apr 1, 2023 | Apr 1, 2023 | Apr 1, 2024 | Apr 1, 2024 | Apr 1, 2025 | -- |
End Date | Mar 31, 2023 | Sep 30, 2023 | Mar 31, 2024 | Sep 30, 2024 | Mar 31, 2025 | Sep 30, 2025 | -- |
Fiscal Year-End | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 | -- |
Revenue | 3.53M -- | 2.64M -- | 6.02M +70.37% | 2.96M +12.00% | 6.22M +3.43% | 2.16M -26.99% | 5.42M -- |
Sales and Services Revenue | 3.53M -- | 2.64M -- | 6.02M +70.37% | 2.96M +12.00% | 6.22M +3.43% | 2.16M -26.99% | 5.42M -- |
Cost of Revenue | 17.36K -- | 4.75K -- | 11.29K -34.92% | 6.29K +32.49% | 15.51K +37.36% | 30.52K +385.11% | 39.74K -- |
Cost of Goods and Services | 17.36K -- | 4.75K -- | 2.80M +16043.28% | 6.29K +32.49% | 2.85M +1.89% | 30.52K +385.11% | 2.88M -- |
Gross Profit | 3.51M -- | 2.64M -- | 3.21M -8.53% | 2.95M +11.96% | 3.37M +4.77% | 2.13M -27.87% | 2.54M -- |
Operating Expenses | 4.03M -- | 2.19M -- | 2.20M -45.35% | 2.40M +9.32% | 1.98M -10.28% | 2.22M -7.24% | 1.80M -- |
Selling, General and Administrative Expenses | 3.86M -- | 2.07M -- | 773.04K -79.99% | 2.23M +7.60% | 696.59K -9.89% | 2.09M -6.04% | 561.93K -- |
Selling and Marketing Expenses | 664.88K -- | 403.69K -- | -- -- | 583.96K +44.65% | -- -- | 355.37K -39.15% | -- -- |
General and Administrative Expenses | 339.89K -- | 150.24K -- | -- -- | 124.36K -17.22% | -- -- | 168.25K +35.29% | -- -- |
Other Operating Expenses | 172.38K -- | 121.31K -- | 1.43M +730.63% | 168.17K +38.63% | 1.28M -10.49% | 129.26K -23.14% | 1.24M -- |
Operating Income | -521.34K -- | 443.69K -- | 1.01M +293.51% | 554.85K +25.05% | 1.39M +37.68% | -94.39K -117.01% | 739.70K -- |
Non-Operating Income (Loss) | 100.87K -- | 253 -- | -5.35K -105.31% | 3.07K +1113.04% | 46.23K +963.45% | 52.29K +1603.75% | 95.45K -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | 0 -- | -- -- | 10.57K -- | -- -- |
Other Non-Operating Income (Loss) | 110.84K -- | -929 -- | 1.18K -98.93% | -13.97K -1403.88% | 2.97K +150.59% | 39.40K +382.04% | 56.34K -- |
Net Interest Expense | 9.97K -- | -1.18K -- | 6.54K -34.43% | -17.04K -1341.62% | -43.26K -761.70% | -2.32K +86.40% | -28.54K -- |
Interest Expense | 20.26K -- | 13.78K -- | 26.05K +28.59% | 11.28K -18.11% | 20.87K -19.87% | 10.97K -2.78% | 20.56K -- |
Interest Income | 10.29K -- | 14.96K -- | 19.51K +89.67% | 28.32K +89.34% | 64.14K +228.68% | 13.28K -53.10% | 49.10K -- |
Pretax Income From Continuing Operations | -420.47K -- | 443.94K -- | 1.00M +338.66% | 557.92K +25.67% | 1.44M +43.02% | -42.10K -107.55% | 835.15K -- |
Income Tax Expense | -84.86K -- | 66.29K -- | 181.75K +314.17% | 89.10K +34.41% | 236.08K +29.89% | 30.88K -65.34% | 177.86K -- |
Current Income Tax | 0 -- | 29.94K -- | -- -- | 49.62K +65.73% | -- -- | 0 -100.00% | -- -- |
Deferred Income Tax | -84.86K -- | 36.35K -- | -- -- | 39.48K +8.62% | -- -- | 30.88K -21.79% | -- -- |
Net Income | -335.61K -- | 377.65K -- | 821.74K +344.85% | 468.82K +24.14% | 1.20M +45.92% | -72.98K -115.57% | 657.29K -- |
Net Income Attributable to Minority Interests | -30.49K -- | 3.29K -- | 43.93K +244.10% | -- -- | 0 -100.00% | -- -- | -- -- |
Net Income Attributable to Owners of the Company | -305.12K -- | 374.36K -- | 777.81K +354.92% | 468.82K +25.23% | 1.20M +54.16% | -72.98K -115.57% | 657.29K -- |
Net Income Attributable to Common Stockholders | -305.12K -- | 374.36K -- | 777.81K +354.92% | 468.82K +25.23% | 1.20M +54.16% | -72.98K -115.57% | 657.29K -- |
Other Comprehensive Income | 2.54K -- | -6.22K -- | -4.07K -260.39% | -3.80K +38.86% | -3.77K +7.18% | 664 +117.46% | 694 -- |
Total Comprehensive Income | -333.07K -- | 371.43K -- | 817.68K +345.50% | 465.01K +25.20% | 1.20M +46.18% | -72.31K -115.55% | 657.98K -- |
Total Comprehensive Income Attributable to Owners of the Company | -333.07K -- | 371.43K -- | 817.68K +345.50% | 465.01K +25.20% | 1.20M +46.18% | -72.31K -115.55% | 657.98K -- |
Basic EPS | -0.02 -- | 0.02 -- | 0.05 +350.00% | 0.03 +50.00% | 0.08 +60.00% | 0 -100.00% | 0.05 -- |
Basic EPS from Continuing Operations | -0.02 -- | 0.02 -- | 0.05 +350.00% | 0.03 +50.00% | 0.08 +60.00% | 0 -100.00% | 0.05 -- |
Diluted EPS | -0.02 -- | 0.02 -- | 0.05 +350.00% | 0.03 +50.00% | 0.08 +60.00% | 0 -100.00% | 0.05 -- |
Diluted EPS from Continuing Operations | -0.02 -- | 0.02 -- | 0.05 +350.00% | 0.03 +50.00% | 0.08 +60.00% | 0 -100.00% | 0.05 -- |
You can ask Aime
What is the market's earnings forecast for Charming Medical next quarter?What is Charming Medical's gross profit margin?What factors drove the changes in Charming Medical's revenue and profit?Did Charming Medical beat or miss consensus estimates last quarter?What is Charming Medical's latest dividend and current dividend yield?What does Charming Medical do and what are its main business segments?What were the key takeaways from Charming Medical's earnings call?What is the revenue and EPS growth rate for Charming Medical year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
